It's Tuesday, October 14th.

Welcome to Market Foolery.

I'm Chris Hill joining me in studio today from Motley Full One, Jason Moser.

Thanks for being here, man.

Hey, hey, we got a lot going on.

Yes, we do. We've got some housing stuff,

we've got some pizza to discuss, the business of pizza.

Uh, we've got the, uh, the, uh, the, the, the,

thing, uh, the, the, uh, the, the, uh, the, the, uh, the, We've got the... I knew we shouldn't have taped this before lunch.

We've got Berkshire Hathaway in the news.

Let's start though with Johnson and Johnson.

Help me out here, man. Third quarter profits, higher than

expected, they raised guidance. And stock down, not a lot, but stock down about 1.5 percent.

What's going on here?

Yeah, I mean, it's, I think with Johnson and Johnson, one, you have a very big company that

you know, it's obviously not a growth story per se.

I mean, this is going to be more of an income style investment.

I think that, you know, for a company this size,

growing the top line at that rate, five, six, seven percent,

you know, they do a great job of bringing results down to the bottom line and that's why you

saw that that raise in the earnings guidance. The pharmaceutical division is really

what's driving the bus here for this company. The growth of 18% for the quarter and it accounts for the growth of 18% for the quarter and it accounts for 55% of the company's operating profits.

...